Archford Capital Strategies’s Idexx Laboratories IDXX Stock Holding History

Archford Capital Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Sell	1,903 -1,058	-36%	-$593K	0.1%	174
2026 Q1	$1.66M	Buy	+2,961	New	+$1.9M	0.19%	117
2018 Q2	–	Sell	-18	Closed	-$3K	–	703
2018 Q1	$3K	Buy	+18	New	+$3.32K	﹤0.01%	461
2017 Q2	–	Sell	-18	Closed	-$3K	–	384
2017 Q1	$3K	Hold	18	–	–	﹤0.01%	545
2016 Q4	$2K	Sell	18 -6	-25%	-$685	﹤0.01%	513
2016 Q3	$2K	Sell	24 -24	-50%	-$2.53K	﹤0.01%	529
2016 Q2	$4K	Buy	+48	New	+$4.12K	﹤0.01%	511
2016 Q1	–	Sell	-64	Closed	-$6K	–	366
2015 Q4	$6K	Buy	64 +30	+88%	+$2.14K	﹤0.01%	524
2015 Q3	$2K	Buy	+34	New	+$2.44K	﹤0.01%	553

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Archford Capital Strategies's IDXX Position: Q2 2026 in Review

Archford Capital Strategies reduced its Idexx Laboratories (IDXX) stake by 36% in Q2 2026, selling an estimated $593K and leaving 1,903 shares worth $1M. The position accounts for 0.1% of the portfolio, ranked #174.

Archford Capital Strategies first reported a position in IDXX in Q3 2015 and has held it in 9 quarters since. The position peaked at $1.66M in Q1 2026. 408 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Archford Capital Strategies held 1,903 shares of Idexx Laboratories worth $1M as of Q2 2026.
Archford Capital Strategies sold 1,058 Idexx Laboratories shares in Q2 2026, an estimated $593K.
Idexx Laboratories made up 0.1% of Archford Capital Strategies's portfolio in Q2 2026, its #174 holding.
Archford Capital Strategies first reported a position in Idexx Laboratories in Q3 2015 and has held it in 9 quarters since.
Archford Capital Strategies's Idexx Laboratories position peaked at $1.66M in Q1 2026.
408 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.